“The acquisition ofSomincor and Zinkgruvan is pivotal to the long-term development of Boliden. I am of course very pleased that we now have concluded the financing of the acquisition, fully in line with the intentions at the announcement of the transaction. We are also grateful for the wide support from our relationship banks, shareholders, and […]

Sappe PCL (SAPPE), a pioneer in beverage innovation from Thailand that has gained recognition among consumers worldwide, is set to reinforce its global brand ambition at THAIFEX – ANUGA ASIA 2025, Asia's premier food and beverage trade exhibition. The event will take place from May 27-31, 2025, at Booth 1-QQ01, Impact Challenger Hall 1, Muang

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofNAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline. So what: If you purchased NAPCO securities during the Class Period

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ibotta, Inc. (NYSE: IBTA): (1) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Ibotta's April 18, 2024 initial public offering (the “IPO”); or (2) between April 18, 2024 and

https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Krispy Kreme, Inc. (NASDAQ: DNUT) between February 25, 2025 and May 7, 2025, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/2598307/32a64817_10ba_407b_947c_76bd790799f6_Logo.jpg So What: If you purchased Iovance securities during the Class Period you may

First Quarter 2025 Highlights: — Sales growth across all business segments in Israel and globally, driven primarily by Brazil — Continued investment in infrastructure in Israel, including a new production facility for plant-based milk alternatives in Northern Israel (expected to be completed by the end of 2025), and new logistics centers inBror Hayil and Yotvata

LONDON, UNITED KINGDOM / ACCESS Newswire / May 28, 2025 / Orosur Mining Inc (TSXV:OMI)(AIM:OMI), the mineral explorer and developer with current operations in Columbia, Argentina and Nigeria, announces that Louis Castro, Executive Chairman and Brad George, Chief Executive Officer, will be holding a live Investor Webinar Q&A session via the Investor Meet Company platform

LONDON, UK / ACCESS Newswire / May 28, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to announce the signing of a Master Service Agreement (MSA) with CER Groupe (CER), a long-standing partner of the Company. CER is a private Belgian research center

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA dual analysis of CTC-DNA and ctDNA GUILDFORD, UNITED KINGDOM / ACCESS Newswire / May 28, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and